Spector, Logan G.

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma

Mirabello, L., Zhu, B., Koster, R., Karlins, E., Dean, M., Yeager, M., Gianferante, M., Spector, L. G., Morton, L. M., Karyadi, D., et al. (2020) · JAMA Oncology

Sarcoma Diagnosis and TreatmentBRCA gene mutations in cancer

Cited by 243

Trends in long-term mortality after congenital heart surgery.

Spector, L. G., Menk, J. S., Knight, J. H., McCracken, C., Thomas, A. S., Vinocur, J. M., Oster, M. E., St Louis, J. D., Moller, J. H., & Kochilas, L. (2018) · Journal of the American College of Cardiology

Congenital Heart Disease StudiesCardiovascular Conditions and Treatments

Cited by 230

Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium

Smith, C. A., McCracken, C., Thomas, A. S., Spector, L. G., St Louis, J. D., Oster, M. E., Moller, J. H., & Kochilas, L. (2019) · JAMA Cardiology

Congenital Heart Disease StudiesCongenital heart defects research

Cited by 176

Cancer Progress and Priorities: Childhood Cancer

Lupo, P. J., & Spector, L. G. (2020) · Cancer Epidemiology, Biomarkers & Prevention

Global Cancer Incidence and ScreeningAcute Lymphoblastic Leukemia research

Cited by 91

In-hospital vital status and heart transplants after intervention for congenital heart disease in the pediatric cardiac care consortium: completeness of ascertainment using the National Death Index and United Network for Organ Sharing Datasets.

Spector, L. G., Menk, J. S., Vinocur, J. M., Oster, M. E., Harvey, B. A., St. Louis, J. D., Moller, J., & Kochilas, L. K. (2016) · Journal of the American Heart Association

Congenital Heart Disease StudiesMedical Coding and Health Information

Cited by 39

Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma.

Mills, L. J., Spector, L. G., Largaespada, D. A., & Williams, L. A. (2021) · Biology of Sex Differences

Sarcoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 17

Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children’s Oncology Group

Diessner, B. J., Pankratz, N., Hooten, A. J., Mirabello, L., Sarver, A. L., Mills, L. J., Malkin, D., Kelley, A. C., & Spector, L. G. (2020) · JCO Precision Oncology

Sarcoma Diagnosis and TreatmentGenomics and Rare Diseases

Cited by 16